Trial Profile

A phase II study of naloxone nasal spray for the treatment of cocaine use disorder

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 23 Mar 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Naloxone (Primary)
Indications Cocaine-related disorders
Focus Therapeutic Use
Sponsors Opiant Pharmaceuticals

Most Recent Events

23 Mar 2016 New trial record
16 Mar 2016 According to Opiant Pharmaceuticals media release, company plans to report top-line results by 1Q17.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com